These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21504116)

  • 1. Interference from heterophilic antibodies in amyloid-β oligomer ELISAs.
    Sehlin D; Söllvander S; Paulie S; Brundin R; Ingelsson M; Lannfelt L; Pettersson FE; Englund H
    J Alzheimers Dis; 2010; 21(4):1295-301. PubMed ID: 21504116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced levels of amyloid beta-peptide antibody in Alzheimer disease.
    Du Y; Dodel R; Hampel H; Buerger K; Lin S; Eastwood B; Bales K; Gao F; Moeller HJ; Oertel W; Farlow M; Paul S
    Neurology; 2001 Sep; 57(5):801-5. PubMed ID: 11552007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue.
    Bruggink KA; Jongbloed W; Biemans EA; Veerhuis R; Claassen JA; Kuiperij HB; Verbeek MM
    Anal Biochem; 2013 Feb; 433(2):112-20. PubMed ID: 23022042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples.
    Kasai T; Tokuda T; Taylor M; Kondo M; Mann DM; Foulds PG; Nakagawa M; Allsop D
    Neurosci Lett; 2013 Sep; 551():17-22. PubMed ID: 23811027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive aβ oligomer assay discriminates Alzheimer's and aged control cerebrospinal fluid.
    Savage MJ; Kalinina J; Wolfe A; Tugusheva K; Korn R; Cash-Mason T; Maxwell JW; Hatcher NG; Haugabook SJ; Wu G; Howell BJ; Renger JJ; Shughrue PJ; McCampbell A
    J Neurosci; 2014 Feb; 34(8):2884-97. PubMed ID: 24553930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF.
    Yang T; Hong S; O'Malley T; Sperling RA; Walsh DM; Selkoe DJ
    Alzheimers Dement; 2013 Mar; 9(2):99-112. PubMed ID: 23375565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in plasma levels of α-synuclein is evident in patients with Parkinson's disease after elimination of heterophilic antibody interference.
    Ishii R; Tokuda T; Tatebe H; Ohmichi T; Kasai T; Nakagawa M; Mizuno T; El-Agnaf OM
    PLoS One; 2015; 10(4):e0123162. PubMed ID: 25849645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?
    Travassos M; Santana I; Baldeiras I; Tsolaki M; Gkatzima O; Sermin G; Yener GG; Simonsen A; Hasselbalch SG; Kapaki E; Mara B; Cunha RA; Agostinho P; Blennow K; Zetterberg H; Mendes VM; Manadas B; de Mendon A
    J Alzheimers Dis; 2015; 47(4):1069-78. PubMed ID: 26401784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
    Kawarabayashi T; Younkin LH; Saido TC; Shoji M; Ashe KH; Younkin SG
    J Neurosci; 2001 Jan; 21(2):372-81. PubMed ID: 11160418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.
    Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush AM; Moir R; Tanzi RE; Growdon JH; Nitsch RM
    Eur Neurol; 1998; 39(2):111-8. PubMed ID: 9520072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.
    Xia W; Yang T; Shankar G; Smith IM; Shen Y; Walsh DM; Selkoe DJ
    Arch Neurol; 2009 Feb; 66(2):190-9. PubMed ID: 19204155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma.
    Vanderstichele H; Van Kerschaver E; Hesse C; Davidsson P; Buyse MA; Andreasen N; Minthon L; Wallin A; Blennow K; Vanmechelen E
    Amyloid; 2000 Dec; 7(4):245-58. PubMed ID: 11132093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β oligomers relate to cognitive decline in Alzheimer's disease.
    Jongbloed W; Bruggink KA; Kester MI; Visser PJ; Scheltens P; Blankenstein MA; Verbeek MM; Teunissen CE; Veerhuis R
    J Alzheimers Dis; 2015; 45(1):35-43. PubMed ID: 25547634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model.
    Cho SM; Kim HV; Lee S; Kim HY; Kim W; Kim TS; Kim DJ; Kim Y
    Sci Rep; 2014 Oct; 4():6777. PubMed ID: 25345439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease.
    Kasai T; Kondo M; Ishii R; Tanaka A; Ataka S; Shimada H; Tomiyama T; Mori H; Taylor M; Allsop D; Nakagawa M; Mizuno T; Tokuda T
    PLoS One; 2017; 12(4):e0174630. PubMed ID: 28394917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
    J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease.
    Teunissen CE; Chiu MJ; Yang CC; Yang SY; Scheltens P; Zetterberg H; Blennow K
    J Alzheimers Dis; 2018; 62(4):1857-1863. PubMed ID: 29614646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of heterophilic antibodies in serum samples from horses in an equine hospital, and elimination of interference using chicken IgY.
    Dong B; Bergman D; Holst BS
    Acta Vet Scand; 2021 Mar; 63(1):10. PubMed ID: 33712042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amyloid-β oligomer count in cerebrospinal fluid is a biomarker for Alzheimer's disease.
    Wang-Dietrich L; Funke SA; Kühbach K; Wang K; Besmehn A; Willbold S; Cinar Y; Bannach O; Birkmann E; Willbold D
    J Alzheimers Dis; 2013; 34(4):985-94. PubMed ID: 23313925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.